Vivan Therapeutics is a UK-based biotech start-up focused on developing decision platforms for personalized cancer therapeutics. ABI has collaborated with Vivan since 2022, under a service provision agreement. ABI recruited and supervises a team of bioinformaticians and data scientists who get directly involved in the R&D activities of Vivan Therapeutics. The research focuses on genetic biomarker discovery for cancer precision diagnostics & treatment decisions using ML classification & -omics integration in combination with drug screening of genetic flie-models.
People
Supervisor
University of Leipzig
ABI Chairman
ABI Data Scientists
MSc student
MSc student